CCAT2 and colorectal carcinoma: Even though these results support the differential expression of CCAT2 in CRC samples when comparing with normal tissue and in metastatic vs non-metastatic CRC, they show that when integrating the CCAT2 expression level into the global genomic alterations that occur in cancer, its role fails to significantly influence the previously described ColoMet19 predictor [54].